Sarcopenia, Eosinophil-to-Platelet Ratio, and C-reactive Protein as Predictors of Adverse Events in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Prospective Observational Study

Background: Biomarkers such as sarcopenia, eosinopenia, and C-reactive protein (CRP) may predict adverse events in chronic obstructive pulmonary disease (COPD) exacerbations. We aimed to determine their prognostic utility and accuracy versus conventional measures. Methods: This was a prospective analysis of COPD patients hospitalized for acute exacerbations for more than one year. Patients with primary diagnoses other than COPD were excluded. A total of 200 participants were screened, and 50 experienced adverse events, including mortality, rehospitalization, prolonged stay, hypoxemia, or hypercapnia. Data on demographics, lung function, symptoms, nutrition, frailty, sarcopenia, the eosinophil-to-platelet ratio (EPR), and CRP were extracted. Differences between groups were analyzed using t-tests and regression modeling. Results: Elevated CRP and a low EPR were significant predictors of adverse events after adjustment, with CRP having an area under the curve (AUC) of 0.71 (0.64-0.80) and EPR having an AUC of 0.76 (0.61-0.79) for composite outcomes. According to the multivariate logistic regression analysis, sarcopenia (adjusted Or (aOR)-1.97 (1.87-4.44)), EPR (aOR-2.33 (1.02-5.32)), and CRP (aOR-2.09 (1.01-3.18)) remained significant. Conclusion: The EPR and CRP levels are useful prognostic markers of in-hospital morbidity and mortality during COPD exacerbations. However, multidimensional assessments incorporating other treatable traits may further optimize risk prediction and reduce adverse outcomes.

• Publication year

  2024

• Venue

  Cureus

• Publication date

  2024-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.7759/cureus.56651PMID 38646255PMCID 11032177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Low Eosinophil to Platelet Ratio as a Worse Prognostic Index for Emergency Department Attendance in Acute Exacerbation of COPD

  2024influential reference
• Prevalence of sarcopenia in patients with COPD through different musculature measurements: An updated meta-analysis and meta-regression

  2023cited by this paper
• Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study

  2023cited by this paper
• Incorporating Biomarkers in COPD Management: The Research Keeps Going

  2022cited by this paper
• Comparison of CRP, Procalcitonin, Neutrophil Counts, Eosinophil Counts, sTREM-1, and OPN between Pneumonic and Nonpneumonic Exacerbations in COPD Patients

  2022influential reference
• Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysis

  2020cited by this paper
• Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis

  2020cited by this paper
• Sarcopenia: revised European consensus on definition and diagnosis

  2018influential reference
• Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

  2017cited by this paper
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

  2017cited by this paper
• Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study

  2016cited by this paper
• Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives

  2015cited by this paper
• Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD

  2015cited by this paper
• Nutritional assessment and therapy in COPD: a European Respiratory Society statement

  2014cited by this paper
• Adverse outcomes of frailty in the elderly: the Rotterdam Study

  2014cited by this paper
• COPD Assessment Test: A Simple Tool to Evaluate Disease Severity and Response to Treatment

  2014influential reference
• Eosinophilic phenotypes of airway disease.

  2013cited by this paper
• Rehabilitation and acute exacerbations

  2011cited by this paper
• Susceptibility to exacerbation in chronic obstructive pulmonary disease.

  2010cited by this paper
• Validation of the Mini Nutritional Assessment short-form (MNA®-SF): A practical tool for identification of nutritional status

  2009influential reference
• A global clinical measure of fitness and frailty in elderly people

  2005influential reference
• The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

  2004cited by this paper

• Frailty in COPD: Clinical Impact, Diagnosis, Biomarkers, and Management Strategies

  2025cites this paper
• A Pilot Study on Proteomic Predictors of Mortality in Stable COPD

  2024cites this paper